Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 17, 2021
[ Wed, Nov 17th 2021
] - WOPRAI
[ Wed, Nov 17th 2021
] - WOPRAI
[ Wed, Nov 17th 2021
] - WOPRAI
[ Wed, Nov 17th 2021
] - WOPRAI
[ Wed, Nov 17th 2021
] - WOPRAI
Tue, November 16, 2021
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
Brian Abrahams Maintained (ATAI) at Hold with Decreased Target to $17 on, Nov 16th, 2021
Brian Abrahams of RBC Capital, Maintained "Atai Life Sciences N.V." (ATAI) at Hold with Decreased Target from $19 to $17 on, Nov 16th, 2021.
Brian has made no other calls on ATAI in the last 4 months.
There are 4 other peers that have a rating on ATAI. Out of the 4 peers that are also analyzing ATAI, 0 agree with Brian's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Brian
- Elemer Piros of "Roth Capital" Initiated at Strong Buy and Held Target at $32 on, Thursday, November 11th, 2021
- Patrick Trucchio of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $40 on, Monday, October 18th, 2021
- Andrew Tsai of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Wednesday, September 1st, 2021
- Nathan Weinstein of "Argus Research" Maintained at Strong Buy with Increased Target to $27 on, Tuesday, August 17th, 2021
